Aristotle University Of Thessaloniki (AUTH)
Φαρμακοκινητικές αλληλεπιδράσεις φαρμάκων με φυτοθεραπευτικά σκευάσματα
Abstract
dc:descriptionHerbal medicinal products (HMPs) are trade products that consist of one or more phytochemical compounds or one or more plant materials. The HMPs are characterised and market distributed as dietary supplements or Complementary and Alternative Medicines (CAM). The concomitant use of HMPs and prescribed medications from patients is of wide concern in clinical practice, since their concurrent administration with drugs can affect the safety and efficacy profiles of prescribed medications. The aim of this study had been to investigate the potential and clinical significance of pharmacokinetic interactions of drugs with trade herbal preparations. The study focused on the efflux activity of P-glycoprotein (P-gp) which plays a significant role in the absorption and the metabolism of drugs mediated from cytochromes P-450 (CYPs). The effects of trade herbal preparations on P-gp function in Caco-2 cell monolayers were investigated by measuring the apparent permeability coefficient of Rhodamine-123. The metabolic activity mediated by recombinant CYPs was investigated by measuring the metabolism of probe drugs such as phenacetin through CYP1A2, S-warfarin through CYP2C9 and dextromethorphan through both CYP2D6 and CYP3A4. To this respect SIM GC/MS and HPLC/UV analytical methods were developed and validated in order to quantify the probe substrates and their metabolites. The in vitro observations were further estimated with the Simcyp® population-based pharmacokinetic simulator in an attempt to estimate the clinical significance of the in vitro data and lead to an in vivo study investigating the possible pharmacokinetic interactions with losartan a substrate of both P-gp and the cytochromes P-450 CYP2C9 and CYP3A4. The trade herbal products which were chosen to this study were Agnus castus, Aloe vera, Artichoke, Crocus sativus, Evening primrose oil, Ginseng, Guarana, Hawthorn, Hedera helix, Horse chestnut, Lobelia, Rhodiolarosea and Senna. The results from incubations with Caco-2 and recombinant CYPs showed that Rhodiola rosea, Artichoke, Agnus castus, Ginseng and Senna were found to be the most potent regarding the inhibition of P-gp and CYP-metabolism. The results from the Simcyp® revealed that Rhodiola rosea and Artichoke could be candidates for in vivo clinical studies. An in vivo pharmacokinetic study in rabbits regarding the interaction of losartan and Rhodiola rosea confirmed the estimation from the in vitro results and Simcyp® simulations.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Spanakis, Marios
- Σπανάκης, Μάριος
Subjects
dc:subject × 20- Φαρμακοκινητική
- ΑΛΛΗΛΕΠΙΔΡΑΣΕΙΣ ΦΑΡΜΑΚΩΝ
- Βιοαναλυτικές μέθοδοι
- Caco-2 κύτταρα
- Κυτοχρώματα Ρ450
- Φυτικά Φαρμακευτικά Προϊόντα
- ΡΒ/ΡΚ μοντέλα
- Φαρμακολογία
- Pharmacokinetics
- DRUG INTERACTIONS
- Bioanalytical methods
- Caco-2 cells
- Cytochromes P450
- Herbal Medicinal Products
- PB/PK models
- Pharmacology
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27628